超声介入无水乙醇量化治疗合并肝硬化的复发性肝癌的临床效果研究  

Effect of Ultrasonic Intervention in the Treatment of Recurrent Liver Cancer Patients with Liver Cirrhosis

作　　者：孙思 李春 SUN Si;LI Chun(Xinqiao Hospital of Shapingba District,Chongqing 400037,China)

机构地区：[1]陆军军医大学第二附属医院超声科,400037

出　　处：《中国全科医学》2017年第B12期182-183,共2页Chinese General Practice

摘　　要：目的探讨超声介入无水乙醇量化治疗合并肝硬化的复发性肝癌患者的临床效果。方法选择沙坪坝区新桥正街新桥医院在2015年间收治的32例合并肝硬化的复发性肝癌患者为研究对象,根据治疗方案将患者均分为化疗组(n=16)和超声组(n=16),化疗组患者接受肝动脉栓塞化疗治疗,超声组患者接受超声介入无水乙醇量化治疗,对比两组患者的临床治疗效果、术后的生存情况及不良反应发生情况。结果超声组患者临床疗效好于化疗组,术后6、12个月生存率高于化疗组,不良反应发生率低于化疗组(P<0.05)。结论超声介入无水乙醇量化治疗合并肝硬化的复发性肝癌患者的临床效果好,不良反应少,值得推广。Objective To analyze the specific effect of ultrasonic intervention in the treatment of recurrent liver cancer patients with liver cirrhosis.Methods Thirty-two patients with recurrent hepatocellular carcinoma(HCC)with cirrhosis were enrolled in this study.All patients were divided into chemotherapy group(n=16)and ultrasound group(n=16)according to the difference of treatment plan.Hepatic artery embolization chemotherapy,ultrasound group patients need to undergo ultrasound interventional ethanol ethanol quantitative treatment,compared the two groups of patients with clinical treatment,postoperative survival and adverse reactions.Results The clinical efficacy of ultrasound group was significantly better than that of chemotherapy group.The survival rate after treatment was higher and the incidence of adverse reactions was lower.There was significant difference between the two groups(P<0.05).Conclusion The treatment of patients with recurrent hepatocellular carcinoma and combined with cirrhosis has a better effect in the treatment of absolute ethanol in patients undergoing ultrasound intervention.

关 键 词：肝硬化 肝肿瘤 乙醇 超声检查 介入性 

分 类 号：R735.7[医药卫生—肿瘤]